What’s New In Diffuse Large B-Cell LymphomaUpdates from ASCO 2024 & the EHA Hybrid Congress

What’s New In Diffuse Large B-Cell LymphomaUpdates from ASCO 2024 & the EHA Hybrid CongressПодробнее

Exciting advancements in NHL from EHA 2024Подробнее

ASCO 2021 Clinical Panel Series - Diffuse Large B-Cell LymphomaПодробнее

Town Hall on ASCO, EHA & ICML - LymphomasПодробнее

Hot Topics In Non-Hodgkin Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

Top highlights from ASCO & EHA 2023Подробнее

What’s New In Follicular Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria IacoboniПодробнее

What’s New In Mantle Cell Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

Update on Diffuse Large B-Cell Lymphoma | Lymphoma Research Foundation WebinarsПодробнее

Update in emerging agents presented at ASCO and EHAПодробнее

ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib Effective in Ph+ ALL & CMLПодробнее

Free Oncology Symposia in Conjunction With 2024 ASCO Annual Meeting - Shmuel Shoham, MDПодробнее

ASCO 2023 rare lymphoma highlights: JACKPOT8, IELSG37, and mogamulizumab + CHOP in ATLПодробнее

Joshua Brody on Epcoritamab Immunotherapy for DLBCL | ASCO 2024Подробнее

Lymphomas in 2024 Changing Standards of Care and Challenging Paradigms Elizabeth Brem, MD from UCIПодробнее

ASCO22 Leukemia Lymphoma Updates | Matthew Lunning, DO, FACP | University of Nebraska Medical CenterПодробнее

DLBCL in 2023: Top Docs Discuss the LATEST in Diffuse Large B-Cell Lymphoma | Treatments & ResearchПодробнее